Keywords: پادتن ویژه پروستات; prostatic neoplasms; biopsy; watchful waitingAS, active surveillance; DWI, diffusion weighted imaging; MR, magnetic resonance; MRI, magnetic resonance imaging; PSA, prostate specific antigen; T2WI, T2-weighted images
مقالات ISI پادتن ویژه پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پادتن ویژه پروستات; prostatic neoplasms; watchful waiting; neoplasm metastasis; risk factors; neoplasm gradingADT, androgen deprivation therapy; AS, active surveillance; DT, doubling time; GP, Gleason pattern; GS, Gleason score; PSA, prostate specific antigen; RP, radical pr
Keywords: پادتن ویژه پروستات; biopsy; prevalence; prostatic neoplasms; risk assessmentMCCL, maximum cancer core length; PSA, prostate specific antigen; TPM, template prostate mapping; TRUS, transrectal ultrasound; UCL, University College London; UK, United Kingdom
Keywords: پادتن ویژه پروستات; prostatic neoplasms; comorbidity; neoplasm grading; neoplasm staging; watchful waitingCCI, Charlson comorbidity index; NCDB, National Cancer Data Base; PC, prostate cancer; PSA, prostate specific antigen; UGUS, upgrading and/or up staging
Keywords: پادتن ویژه پروستات; prostate; prostate specific antigen; mass screening; African American; educationHCP, health care provider; NHW, nonHispanic white; PCa, prostate cancer; PSA, prostate specific antigen; USPSTF, United States Preventive Services Task Force
Keywords: پادتن ویژه پروستات; prostate; prostatectomy; outcome assessment (health care); quality improvement; data collectionBMI, body mass index; EBL, estimated blood loss; GI, gastrointestinal; LOS, length of stay; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; diagnosis; biopsyCV, coefficient of variation; DRE, digital rectal examination; PSA, prostate specific antigen; SABOR, San Antonio Biomarkers of Risk of Prostate Cancer Study
Keywords: پادتن ویژه پروستات; IPSS, International Prostate Symptoms Score; BPH, benign prostatic hyperplasia; PSA, prostate specific antigen; PVR, post-void residual volume; PAE, postatic artery embolization; PVA, polyvinyl alcohol; TURP, transurethral resection of the prostate; QOL,
Keywords: پادتن ویژه پروستات; biological markers; evaluation studies; data collection; prostatic neoplasmsADT, androgen deprivation therapy; AUA, American Urological Association; CCP, cell cycle progression; EBRT, external beam radiation therapy; PSA, prostate specific antigen; VAS, v
Keywords: پادتن ویژه پروستات; prostatic neoplasms; prostate-specific antigen; risk factors; mass screeningERSPC, European Randomized Study of Screening for Prostate Cancer; PCa, prostate cancer; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; biopsy; prostatic neoplasms; prostatectomy; recurrence; neoplasm gradingADT, androgen deprivation therapy; BCR, biochemical recurrence; G4%, percent Gleason pattern 4 involvement; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; prostatic neoplasms; age groups; mortality; prostate cancer; riskCCI, Charlson comorbidity index; CSM, cancer specific mortality; OCM, other cause mortality; PCa, prostate cancer; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; EBRT, external beam radiotherapy; PSA, prostate specific antigen; LHRH, luteinizing hormone releasing hormone; CT, computed axial tomographyAndrogen deprivation; Choroid; Neoplasm metastasis; Prostate cancer; Radiation therapy
Keywords: پادتن ویژه پروستات; prostatic neoplasms; biopsy; prostate-specific antigen; prostatectomy; watchful waitingAS, active surveillance; PSA, prostate specific antigen; SABOR, San Antonio Center of Biomarkers of Risk for Prostate Cancer
Keywords: پادتن ویژه پروستات; prostatic neoplasms; testosterone; androgens; neoplasm grade; SEER programADT, androgen deprivation therapy; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostatic neoplasms; biopsy; watchful waiting; magnetic resonance imaging; age factorsAS, active surveillance; MRI, magnetic resonance imaging; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; prostatic neoplasms; mortality; prostate-specific antigen; mass screening; European continental ancestry groupBMI, body mass index; FH, family history; PCa, prostate cancer; PLCO, Prostate, Lung, Colorectal and Ovarian; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostatic neoplasms; watchful waiting; biopsy; prostate-specific antigen; disease progressionAS, active surveillance; PSA, prostate specific antigen; PSAD, PSA density; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; NET, neuroendocrine tumor; PSA, prostate specific antigen; TNM, tumor node metastasesBiopsy; Carcinoma, Neuroendocrine; Prostate/pathology; Rectal NeoplasmsBiopsia; Carcinoma Neuroendócrino; Neoplasias do Reto; Próstata/patologia
Keywords: پادتن ویژه پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; risk; prognosisc-index, concordance index; DRE, digital rectal examination; PCA, prostate cancer; PSA, prostate specific antigen; SABOR, San Antonio Biomarkers of Risk for Prostate Cancer
Keywords: پادتن ویژه پروستات; prostate; atrophy; prostatic neoplasms; biopsy; prostate-specific antigenPCa, prostate cancer; PIA, proliferative inflammatory atrophy; PIN, prostate intraepithelial neoplasia; PSA, prostate specific antigen; PV, prostate volume
Keywords: پادتن ویژه پروستات; prostatic neoplasms; antiandrogens; cardiovascular diseases; diabetes mellitus; riskADT, androgen deprivation therapy; CVD, cardiovascular disease; DM, diabetes; PCOS, Prostate Cancer Outcomes Study; PSA, prostate specific antigen; SEER, Surveillance, Epi
Keywords: پادتن ویژه پروستات; aspirin; prostatic neoplasms; mortality; prognosisADT, androgen deprivation therapy; CPRD, Clinical Practice Research Datalink; NCDR, National Cancer Data Repository; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostate; adenocarcinoma; neoplasm staging; risk; prognosisDCE, dynamic contrast enhanced; ECE, extracapsular extension; MP, multiparametric; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; RP, radical prostatectomy;
Keywords: پادتن ویژه پروستات; prostatic neoplasms; early detection of cancer; magnetic resonance imaging; elasticity imaging techniques; prostatectomyMRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; SWE, shear wave elastography; TRUS, transrectal
Keywords: پادتن ویژه پروستات; urinary bladder neoplasms; prostate; cystectomy; urinary diversion; mortalityBCI, Bladder Cancer Index; PSA, prostate specific antigen; SHIM, Sexual Health Inventory for Men
Keywords: پادتن ویژه پروستات; prostatic neoplasms; adenocarcinoma; prostate-specific antigen; neoplasm metastasis; SwedenIPR, National Inpatient Register; NPCR, National Prostate Cancer Register; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostate; prostatic hyperplasia; laser therapy; volatilization; organ sizeBPH, benign prostatic hyperplasia; HoLEP, holmium laser enucleation of prostate; I-PSS, International Prostate Symptom Score; PSA, prostate specific antigen; PV, prostate volume; PV
Keywords: پادتن ویژه پروستات; prostatic neoplasms; prostatectomy; physician's practice patterns; elderly; riskLE, life expectancy; LR, low risk; LR percent, percent of LR patients treated with RP in given year by given surgeon; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: پادتن ویژه پروستات; EChT, electrochemical therapy; PCa, prostate cancer; PSA, prostate specific antigen; s.c, subcutaneous; U, voltage; T, temperature; Pt–Ir, Platinum–Iridium; CD, current density; RFS, recurrence-free survival; HR, hazard ratioProstate cancer; Prostate tumo
Keywords: پادتن ویژه پروستات; GO, graphene oxide; TB, thrombin; PSA, prostate specific antigen; HA, hemagglutinin; TBA, thrombin binding aptamer; PSAA, prostate specific antigen binding aptamer; HAA, hemagglutinin binding aptamerGraphene oxide; Aptamer; Oligonucleotide; Fluorescence;
Keywords: پادتن ویژه پروستات; prostatic neoplasms; testosterone; hypogonadism; neoplasm recurrence; local; prognosisAR, androgen receptor; DHT, dihydrotestosterone; DRE, digital rectal examination; FT, free testosterone; PCa, prostate cancer; PSA, prostate specific antigen; SHBG, sex
Keywords: پادتن ویژه پروستات; prostatic neoplasms; neoplasm recurrence; local; radiotherapy; urinary bladder neoplasms; cystectomyBCR, biochemical recurrence; EBRT, external beam RT; PCa, prostate cancer; PSA, prostate specific antigen; RC, radical cystectomy; RT, radiotherapy
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; polymorphism; single nucleotide; organ size; riskBPH, benign prostatic hyperplasia; LUTS, lower urinary tract symptoms; PC, prostate cancer; PSA, prostate specific antigen; SNP, single nucleotide polymorphism
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; Asian Americans; epidemiology; SEER programFB, foreign born; GS, Gleason score; NH, nonHispanic; PCa, prostate cancer; PSA, prostate specific antigen; SES, socioeconomic status; USB, United States born
Keywords: پادتن ویژه پروستات; lower urinary tract symptoms; methamphetamine; prevalence; treatment outcomeBMI, body mass index; LUTS, lower urinary tract symptoms; MA, methamphetamine abuser; METH, methamphetamine; PSA, prostate specific antigen; PV, prostate volume; QoL, quality of l
Keywords: پادتن ویژه پروستات; prostatic neoplasms; biopsy; infection; sepsis; treatment outcomeAS, active surveillance; ESBL, extended spectrum beta-lactamase; FQ, fluoroquinolone; PSA, prostate specific antigen; TRUS, transrectal ultrasound; UTI, urinary tract infection
Keywords: پادتن ویژه پروستات; TRUS, transrectal ultrasonography; DWI, diffusion-weighted imaging; DCE-MRI, dynamic contrast enhanced magnetic resonance imaging; MRSI, magnetic resonance spectroscopic imaging; PSA, prostate specific antigen; Se, Sensitivity; Sp, Specificity; NHS, Natio
Keywords: پادتن ویژه پروستات; prostatic neoplasms; lymphatic metastasis; prostatectomy; treatment outcomeADT, androgen deprivation therapy; CSS, cancer specific survival; PLND, pelvic lymph node dissection; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostate; biopsy; erectile dysfunction; questionnaires; watchful waitingAS, active surveillance; ED, erectile dysfunction; EF, erectile function; PDE-5, phosphodiesterase type 5; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; prostatectomy; venous thromboembolism; ABO blood-group systemDVT, deep venous thrombosis; PE, pulmonary embolism; PSA, prostate specific antigen; RP, radical prostatectomy; VTE, venous thromboembolic event; vWF, von Willebra
Keywords: پادتن ویژه پروستات; prostatic neoplasms; risk; age factors; African Americans; prostate specific antigenAUA, American Urological Association; ERSPC, European Randomized Trial of Screening for Prostate Cancer; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; neoplasm grading; risk; healthcare disparitiesGS, Gleason score; NCCN, National Comprehensive Cancer Network®; NOS, not otherwise specified; PSA, prostate specific antigen; SEER, Surveillance, Epidemiology and End Results; T
Keywords: پادتن ویژه پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; African Americans; AfricaDRE, digital rectal examination; fPSA, free PSA; PSA, prostate specific antigen; PSAD, PSA density; TRUS, transrectal ultrasound
Keywords: پادتن ویژه پروستات; PCa, prostate cancer; PSA, prostate specific antigen; DRE, digital rectal examination; TRUS, transrectal ultrasound; PCA3, Prostate Cancer Antigen 3; TMPRSS2, Transmembrane Protease, Serine 2; CTC, circulating tumour cell; mRNA, messenger RNA; PPV, positi
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; African Americans; risk; neoplasm gradingAA, black; AS, active surveillance; BMI, body mass index; GS, Gleason score; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; PSAD, PSA density;
Keywords: پادتن ویژه پروستات; prostate; prostatic neoplasms; prostate-specific antigen; biopsy; riskAS, active surveillance; NPV, negative predictive value; PPV, positive predictive value; PSA, prostate specific antigen; PSAD, PSA density; PSAV, PSA velocity; RC, risk count
Keywords: پادتن ویژه پروستات; miRNAs, MicroRNAs; BPH, Benign prostatic hyperplasis; PCa, Prostate cancer; PSA, Prostate specific antigen; AR, Androgen receptor; PRDX1, Peroxiredoxin 1; q RT-PCR, Quantitative real time PCR; M, Methylated; U, UnmethylatedProstate cancer; miRNAs; miR-510
Keywords: پادتن ویژه پروستات; prostatic neoplasms; neoplasm grading; biopsy; neoplasm recurrence, local; World Health OrganizationGS, Gleason score; PSA, prostate specific antigen
Keywords: پادتن ویژه پروستات; prostatic neoplasms; magnetic resonance imaging; image-guided biopsympMRI, multiparametric magnetic resonance imaging; MR-F, magnetic resonance-ultrasound fusion; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; ROI,